col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


16 Results       Page 1

 [1] 
Wiley: Cell Proliferation
  original article Date Title Authors   All Authors
1 [GO] 2024―Feb―26 Proteome analysis develops novel plasma proteins classifier in predicting the mortality of COVID-19 Yifei Zeng, Yufan Li, Wanying Zhang, Huidan Lu, Siyi Lin, Wenting Zhang, et al. (+4)
2 [GO] 2023―Oct―11 Integration of human organoids single-cell transcriptomic profiles and human genetics repurposes critical cell type-specific drug targets for severe COVID-19 Yunlong Ma, Yijun Zhou, Dingping Jiang, Wei Dai, Jingjing Li, Chunyu Deng, et al. (+11)
3 [GO] 2023―Mar―20 Post-hospitalization rehabilitation alleviates long-term immune repertoire alteration in COVID-19 convalescent patients Bing Feng, Danwen Zheng, Laijun Yang, Zuqing Su, Lipeng Tang, Ying Zhu, et al. (+19)
4 [GO] 2022―Feb―10 Cellular and molecular atlas of the placenta from a COVID-19 pregnant woman infected at midgestation highlights the defective impacts on foetal health Jingsi Chen, Lili Du, Feiyang Wang, Xuan Shao, Xiaoyi Wang, Wenzhe Yu, et al. (+23)
5 [GO] 2021―Jul―22 Molecular evidence suggesting the persistence of residual SARS-CoV-2 and immune responses in the placentas of pregnant patients recovered from COVID-19 Hao Wu, Shujie Liao, Yiming Wang, Ming Guo, Xingguang Lin, Jianli Wu, et al. (+18)
6 [GO] 2021―Mar―10 Bioinformatic analyses hinted at augmented T helper 17 cell differentiation and cytokine response as the central mechanism of COVID-19-associated Guillain-Barré syndrome Zheng Li, Ziheng Huang, Xingye Li, Cheng Huang, Jianxiong Shen, Shugang Li, et al. (+4)
7 [GO] 2020―Nov―20 Direct inhibitory effect on viral entry of influenza A and SARS-CoV-2 viruses by azithromycin Xiaohong Du, Xiangyang Zuo, Fang Meng, Chenfeng Han, Wei Ouyang, Yu Han, et al. (+4)
8 [GO] 2020―Nov―18 Safety and feasibility of umbilical cord mesenchymal stem cells in patients with COVID-19 pneumonia: A pilot study Ying Feng, Jianying Huang, Jianyuan Wu, Yan Xu, Bo Chen, Lijun Jiang, et al. (+3)
9 [GO] 2020―Nov―03 Network pharmacology and molecular docking analyses on Lianhua Qingwen capsule indicate Akt1 is a potential target to treat and prevent COVID-19 Qi-Dong Xia, Yang Xun, Jun-Lin Lu, Yu-Chao Lu, Yuan-Yuan Yang, Peng Zhou, et al. (+3)
10 [GO] 2020―Oct―27 First case of COVID-19 infused with hESC derived immunity- and matrix-regulatory cells Jun Wu, Zhongjie Hu, Liu Wang, Yuanqing Tan, Wei Hou, Zhongwen Li, et al. (+8)
11 [GO] 2020―Oct―27 Phase 1 trial for treatment of COVID-19 patients with pulmonary fibrosis using hESC-IMRCs Jun Wu, Xing Zhou, Yuanqing Tan, Liu Wang, Tianda Li, Zhongwen Li, et al. (+7)
12 [GO] 2020―Oct―24 Stem cell therapy for COVID-19, ARDS and pulmonary fibrosis Zhongwen Li, Shuaishuai Niu, Baojie Guo, Tingting Gao, Lei Wang, Yukai Wang, et al. (+4)
13 [GO] 2020―Oct―23 Single-cell analysis identified lung progenitor cells in COVID-19 patients Zixian Zhao, Yu Zhao, Yueqing Zhou, Xiaofan Wang, Ting Zhang, Wei Zuo
14 [GO] 2020―Oct―20 Organoid technology demonstrates effects of potential drugs for COVID-19 on the lung regeneration Jianhai Wang, Xue Li, An Wang, Fuxiaonan Zhao, Qi Wu, Li Li, et al. (+3)
15 [GO] 2020―Oct―20 Impaired lung regeneration after SARS-CoV-2 infection Hongxia Shao, Zhonghua Qin, Bei Geng, Junping Wu, Lixia Zhang, Qiuyang Zhang, et al. (+3)
16 [GO] 2020―Oct―19 Detection of SARS-CoV-2 in saliva and characterization of oral symptoms in COVID-19 patients Lili Chen, Jiajia Zhao, Jinfeng Peng, Xiaoshuang Li, Xuliang Deng, Zhi Geng, et al. (+6)
 [1] 

16 Results       Page 1


[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.003 sec